Want to see AU:IDT full AI Analyst Report?

IDT Australia Limited (IDT) Price & Analysis

4 Followers

IDT Stock Chart & Stats

AU$0.05

>-AU$0.01(-1.87%)

At close: Jan 09 4:00 PM EST

AU$0.05

>-AU$0.01(-1.87%)

Day’s Range― - ―

52-Week RangeAU$0.03 - AU$0.11

Previous CloseN/A

Volume22.00K

Average Volume (3M)336.94K

Market Cap

AU$16.86M

Enterprise ValueAU$22.47M

Total Cash (Recent Filing)AU$1.93M

Total Debt (Recent Filing)AU$9.86M

Price to Earnings (P/E)―

Beta1.07

Next Earnings

Aug 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding427,425,570

10 Day Avg. Volume373,970

30 Day Avg. Volume336,941

Financial Highlights & Ratios

PEG Ratio-0.21

Price to Book (P/B)1.73

Price to Sales (P/S)1.92

P/FCF Ratio-5.03

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.01

Revenue Forecast (FY)AU$32.00M

Bulls Say, Bears Say

Bulls Say

CDMO Fee-for-service ModelA fee-for-service CDMO model generates durable, contract-driven revenues independent of product commercialization risk. This business mixes development and manufacturing fees, allowing cash generation from customer workstreams and steady demand from pharma clients, supporting long-term revenue visibility if wins continue.

Australian Manufacturing CapabilitiesOwning compliant manufacturing sites in Australia provides regulatory credibility and near-shore supply for customers, forming a structural advantage versus pure-service competitors. End-to-end capabilities (formulation to finished dose) increase client stickiness and create higher barriers to entry for new local competitors.

Sustained Modest Revenue GrowthPositive top-line growth indicates underlying demand for IDT's services and ability to win or expand contracts. Even modest, consistent revenue gains can support operational leverage over time, helping absorption of fixed costs and offering a runway to move toward profitability if margins are addressed.

Bears Say

Persistent Negative ProfitabilityOngoing negative EBIT and net margins erode retained earnings and impair reinvestment into capacity or commercial initiatives. Persistent losses reduce strategic flexibility, force reliance on external funding, and make it harder to attract long-term investors or partners until margins turn positive.

Negative Operating And Free Cash FlowSustained negative operating and free cash flows constrain the firm's ability to fund working capital, service debt, or invest in plant upgrades. This structural cash generation weakness increases the probability of equity or debt raises and limits discretionary spending on growth-driving projects.

Rising Leverage And Negative ROEHigher leverage combined with negative ROE magnifies financial risk: borrowed capital is not delivering returns, increasing interest burden and reducing financial flexibility. This dynamic raises refinancing risk and can limit capacity to pursue strategic investments or absorb demand variability.

IDT Australia Limited News

IDT Australia Director Geoffrey Sam Increases Indirect Shareholding

An update from IDT Australia Limited ( ($AU:IDT) ) is now available. IDT Australia Limited has reported a...

3M ago

IDT

IDT Australia tips sharp earnings improvement on Sanofi tie-up and US policy tailwinds

IDT Australia Limited ( ($AU:IDT) ) has issued an announcement. IDT Australia has reported that, despite a weak...

3M ago

IDT

IDT Australia Director Increases Indirect Shareholding via On-Market Trades

IDT Australia Limited ( ($AU:IDT) ) has provided an update. IDT Australia director Mark Simari has increased his...

4M ago

IDT

IDT Australia Tightens Governance with Revised Security Trading Policy

The latest announcement is out from IDT Australia Limited ( ($AU:IDT) ). IDT Australia Limited has updated its...

4M ago

IDT

IDT Australia Director Increases Indirect Shareholding via On-Market Purchase

IDT Australia Limited ( ($AU:IDT) ) has provided an update. IDT Australia has disclosed a change in director...

5M ago

IDT

IDT Australia Cancels 164,000 Shares After Conditional Rights Lapse

An announcement from IDT Australia Limited ( ($AU:IDT) ) is now available. IDT Australia Limited has announced the...

7M ago

IDT

IDT Australia Director Increases Shareholding

IDT Australia Limited ( ($AU:IDT) ) has shared an update. IDT Australia Limited announced a change in the...

8M ago

IDT

IDT Australia Limited Successfully Concludes Annual General Meeting

The latest update is out from IDT Australia Limited ( ($AU:IDT) ). IDT Australia Limited announced the results...

8M ago

IDT

IDT Australia Limited’s Cautious Approach in AGM Presentation

IDT Australia Limited ( ($AU:IDT) ) has provided an update. IDT Australia Limited’s recent presentation at their Annual...

8M ago

IDT

IDT Australia Limited Announces Cessation of Securities

IDT Australia Limited ( ($AU:IDT) ) has issued an announcement. IDT Australia Limited announced the cessation of 2,155,000...

9M ago

IDT

IDT FAQ

What was IDT Australia Limited’s price range in the past 12 months?

IDT Australia Limited lowest share price was AU$0.03 and its highest was AU$0.10 in the past 12 months.

What is IDT Australia Limited’s market cap?

IDT Australia Limited’s market cap is AU$16.86M.

When is IDT Australia Limited’s upcoming earnings report date?

IDT Australia Limited’s upcoming earnings report date is Aug 25, 2026 which is in 32 days.

How were IDT Australia Limited’s earnings last quarter?

IDT Australia Limited released its earnings results on Feb 17, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.

Is IDT Australia Limited overvalued?

According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does IDT Australia Limited pay dividends?

IDT Australia Limited pays a Semiannually dividend of AU$0.008 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here

What is IDT Australia Limited’s EPS estimate?

IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does IDT Australia Limited have?

IDT Australia Limited has 427,425,570 shares outstanding.

What happened to IDT Australia Limited’s price movement after its last earnings report?

IDT Australia Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 25.581%.

Which hedge fund is a major shareholder of IDT Australia Limited?

Currently, no hedge funds are holding shares in AU:IDT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

IDT Australia Limited Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-8.11%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

IDT Australia Limited

IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms. Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.